|
GFPT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.917700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.696000E-02 |
| Normal-vs-Stage2 |
6.090800E-01 |
| Normal-vs-Stage3 |
2.10159999999293E-05 |
| Normal-vs-Stage4 |
4.267600E-02 |
| Stage1-vs-Stage2 |
4.307400E-01 |
| Stage1-vs-Stage3 |
9.275300E-03 |
| Stage1-vs-Stage4 |
5.059600E-01 |
| Stage2-vs-Stage3 |
4.040100E-02 |
| Stage2-vs-Stage4 |
2.662200E-01 |
| Stage3-vs-Stage4 |
3.974200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.389900E-04 |
| Normal-vs-AfricanAmerican |
1.056040E-01 |
| Normal-vs-Asian |
5.322500E-03 |
| Caucasian-vs-AfricanAmerican |
4.154800E-01 |
| Caucasian-vs-Asian |
8.112400E-01 |
| AfricanAmerican-vs-Asian |
4.180800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.058800E-03 |
| Normal-vs-Female |
2.421500E-02 |
| Male-vs-Female |
1.120400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.086500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.580720E-03 |
| Normal-vs-Age(61-80Yrs) |
1.665840E-02 |
| Normal-vs-Age(81-100Yrs) |
3.612500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.101400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.721400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.741820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.773000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.238200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.658000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.560400E-02 |
| Classical-VS-Follicular |
1.037440E-01 |
| Classical-VS-Other |
4.442100E-03 |
| Classical-VS-Normal |
6.638100E-03 |
| Tall-VS-Follicular |
9.158500E-03 |
| Tall-VS-Other |
1.239030E-01 |
| Tall-VS-Normal |
5.604000E-04 |
| Follicular-VS-Other |
3.787700E-04 |
| Follicular-VS-Normal |
7.896600E-01 |
| Other-VS-Normal |
1.243730E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.204400E-02 |
| Normal-vs-N1 |
2.198200E-04 |
| N0-vs-N1 |
3.001500E-02 |
|
|
